Penn State University: Repurposing FDA-approved drugs may help combat COVID-19

Several FDA-approved drugs — including for type 2 diabetes, hepatitis C and HIV — significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists at Penn State. Specifically

Related Keywords

, Evaj Pell , Katsuhiko Murakami , Joyce Jose , Anoop Narayanan , Manju Narwal , Communications Biology , Laboratory For Advanced Biological Research At Penn , Penn State , Advanced Biological Research ,